Ma Kuang Healthcare Holding Ltd
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consul… Read more
Ma Kuang Healthcare Holding Ltd (4139) - Net Assets
Latest net assets as of September 2025: NT$503.05 Million TWD
Based on the latest financial reports, Ma Kuang Healthcare Holding Ltd (4139) has net assets worth NT$503.05 Million TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.35 Billion) and total liabilities (NT$844.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$503.05 Million |
| % of Total Assets | 37.32% |
| Annual Growth Rate | -1.98% |
| 5-Year Change | -24.19% |
| 10-Year Change | N/A |
| Growth Volatility | 12.2 |
Ma Kuang Healthcare Holding Ltd - Net Assets Trend (2015–2024)
This chart illustrates how Ma Kuang Healthcare Holding Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ma Kuang Healthcare Holding Ltd (2015–2024)
The table below shows the annual net assets of Ma Kuang Healthcare Holding Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$508.03 Million | +8.33% |
| 2023-12-31 | NT$468.98 Million | -3.95% |
| 2022-12-31 | NT$488.29 Million | -7.64% |
| 2021-12-31 | NT$528.70 Million | -21.11% |
| 2020-12-31 | NT$670.16 Million | +11.67% |
| 2019-12-31 | NT$600.13 Million | +8.14% |
| 2018-12-31 | NT$554.96 Million | +4.26% |
| 2017-12-31 | NT$532.30 Million | +10.48% |
| 2016-12-31 | NT$481.79 Million | -20.81% |
| 2015-12-31 | NT$608.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ma Kuang Healthcare Holding Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4106800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | NT$475.44 Million | 103.66% |
| Total Equity | NT$458.64 Million | 100.00% |
Ma Kuang Healthcare Holding Ltd Competitors by Market Cap
The table below lists competitors of Ma Kuang Healthcare Holding Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Decibel Cannabis Company Inc
OTCQB:DBCCF
|
$18.01 Million |
|
Astino Bhd
KLSE:7162
|
$18.01 Million |
|
Upsales Technology AB
ST:UPSALE
|
$18.02 Million |
|
Dotz Nano Limited
OTCQB:DTZZF
|
$18.02 Million |
|
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
|
$18.00 Million |
|
BRAVE BISON GR.PLC LS-001
F:RT7
|
$18.00 Million |
|
DocCheck AG
XETRA:AJ91
|
$18.00 Million |
|
Omnisystem Co.Ltd
KQ:057540
|
$18.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ma Kuang Healthcare Holding Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 408,570,000 to 458,641,000, a change of 50,071,000 (12.3%).
- Net income of 10,282,000 contributed positively to equity growth.
- Other factors increased equity by 39,789,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$10.28 Million | +2.24% |
| Other Changes | NT$39.79 Million | +8.68% |
| Total Change | NT$- | 12.26% |
Book Value vs Market Value Analysis
This analysis compares Ma Kuang Healthcare Holding Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.22x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$10.73 | NT$23.90 | x |
| 2018-12-31 | NT$11.38 | NT$23.90 | x |
| 2019-12-31 | NT$12.46 | NT$23.90 | x |
| 2020-12-31 | NT$13.38 | NT$23.90 | x |
| 2021-12-31 | NT$10.94 | NT$23.90 | x |
| 2022-12-31 | NT$10.11 | NT$23.90 | x |
| 2023-12-31 | NT$9.60 | NT$23.90 | x |
| 2024-12-31 | NT$10.78 | NT$23.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ma Kuang Healthcare Holding Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.91%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 3.08x
- Recent ROE (2.24%) is above the historical average (0.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -11.67% | -6.10% | 0.77x | 2.49x | NT$-109.39 Million |
| 2016 | -15.08% | -6.80% | 0.86x | 2.59x | NT$-103.70 Million |
| 2017 | 9.17% | 4.44% | 0.87x | 2.36x | NT$-3.79 Million |
| 2018 | 5.60% | 2.91% | 0.83x | 2.31x | NT$-21.30 Million |
| 2019 | 12.75% | 6.63% | 0.73x | 2.62x | NT$14.60 Million |
| 2020 | 13.54% | 8.48% | 0.64x | 2.49x | NT$20.18 Million |
| 2021 | 8.27% | 4.02% | 0.71x | 2.89x | NT$-8.06 Million |
| 2022 | -7.18% | -2.92% | 0.68x | 3.61x | NT$-73.92 Million |
| 2023 | -10.41% | -3.49% | 0.78x | 3.84x | NT$-83.39 Million |
| 2024 | 2.24% | 0.91% | 0.80x | 3.08x | NT$-35.58 Million |
Industry Comparison
This section compares Ma Kuang Healthcare Holding Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,755,728,000
- Average return on equity (ROE) among peers: 28.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ma Kuang Healthcare Holding Ltd (4139) | NT$503.05 Million | -11.67% | 1.68x | $18.00 Million |
| Universal Vision Biotechnology Co Ltd (3218) | $3.76 Billion | 28.35% | 0.53x | $216.57 Million |